447 related articles for article (PubMed ID: 23563320)
21. OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell.
Chen J; He JQ; Zhen SY; Huang LQ
Rheumatol Int; 2012 Dec; 32(12):3993-8. PubMed ID: 22210270
[TBL] [Abstract][Full Text] [Related]
22. High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitor.
Chen T; Knapp AC; Wu Y; Huang J; Lynch JS; Dickson JK; Lawrence RM; Feyen JH; Agler ML
Assay Drug Dev Technol; 2006 Aug; 4(4):387-96. PubMed ID: 16945012
[TBL] [Abstract][Full Text] [Related]
23. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation.
Fu Y; Gu J; Wang Y; Yuan Y; Liu X; Bian J; Liu ZP
J Vet Sci; 2015; 16(2):151-6. PubMed ID: 25549213
[TBL] [Abstract][Full Text] [Related]
24. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE(2) production in chondrocytes.
Honda K
J Oral Sci; 2011 Mar; 53(1):87-96. PubMed ID: 21467819
[TBL] [Abstract][Full Text] [Related]
26. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of matrix metalloproteinase-9 activity by doxycycline ameliorates RANK ligand-induced osteoclast differentiation in vitro and in vivo.
Franco GC; Kajiya M; Nakanishi T; Ohta K; Rosalen PL; Groppo FC; Ernst CW; Boyesen JL; Bartlett JD; Stashenko P; Taubman MA; Kawai T
Exp Cell Res; 2011 Jun; 317(10):1454-64. PubMed ID: 21420951
[TBL] [Abstract][Full Text] [Related]
28. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
29. Advanced glycation end products biphasically modulate bone resorption in osteoclast-like cells.
Li Z; Li C; Zhou Y; Chen W; Luo G; Zhang Z; Wang H; Zhang Y; Xu D; Sheng P
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E355-66. PubMed ID: 26670486
[TBL] [Abstract][Full Text] [Related]
30. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
31. Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.
Goto H; Hozumi A; Osaki M; Fukushima T; Sakamoto K; Yonekura A; Tomita M; Furukawa K; Shindo H; Baba H
Cytokine; 2011 Dec; 56(3):662-8. PubMed ID: 21963155
[TBL] [Abstract][Full Text] [Related]
32. Quercetin triggers apoptosis of lipopolysaccharide (LPS)-induced osteoclasts and inhibits bone resorption in RAW264.7 cells.
Guo C; Hou GQ; Li XD; Xia X; Liu DX; Huang DY; Du SX
Cell Physiol Biochem; 2012; 30(1):123-36. PubMed ID: 22759961
[TBL] [Abstract][Full Text] [Related]
33. Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression.
Kobayashi Y; Hashimoto F; Miyamoto H; Kanaoka K; Miyazaki-Kawashita Y; Nakashima T; Shibata M; Kobayashi K; Kato Y; Sakai H
J Bone Miner Res; 2000 Oct; 15(10):1924-34. PubMed ID: 11028444
[TBL] [Abstract][Full Text] [Related]
34. Effects and mechanism of aromatic aminoketone SY0916 on osteoclastic bone destruction.
Wang L; Peng SY; Liu Y; Li P; Wang WJ
Acta Pharmacol Sin; 2010 Apr; 31(4):470-5. PubMed ID: 20208552
[TBL] [Abstract][Full Text] [Related]
35. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH
Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286
[TBL] [Abstract][Full Text] [Related]
36. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
37. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
38. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
[TBL] [Abstract][Full Text] [Related]
39. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue.
Alwood JS; Shahnazari M; Chicana B; Schreurs AS; Kumar A; Bartolini A; Shirazi-Fard Y; Globus RK
J Interferon Cytokine Res; 2015 Jun; 35(6):480-7. PubMed ID: 25734366
[TBL] [Abstract][Full Text] [Related]
40. Sargachromanol G inhibits osteoclastogenesis by suppressing the activation NF-κB and MAPKs in RANKL-induced RAW 264.7 cells.
Yoon WJ; Kim KN; Heo SJ; Han SC; Kim J; Ko YJ; Kang HK; Yoo ES
Biochem Biophys Res Commun; 2013 May; 434(4):892-7. PubMed ID: 23611776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
